Oxford Lasers has released the latest generation of its fully integrated Envision Pharma system solution to generate FDA compliant data for pulmonary device development. Aimed at manufacturers and testers of pMDIs, DPIs and Nasal sprays, it offers automated spray pattern and plume geometry measurements.
The system gives full compliance with FDA 21 CFR pt. 11 requirements and is designed with GMP in mind. Envision Pharma is available in both manually operated and automatically actuated versions for complete flexibility with different devices and lab requirements in mind.
The R&D version offers additional capability including collecting high-speed movies of device actuation allowing flow-visualisation and flow-velocity measurements to be carried out.
